CVS vs HUM

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 02, 2026

CVS

65.6
AI Score
VS
CVS Wins

HUM

64.6
AI Score

Investment Advisor Scores

CVS

66score
Recommendation
HOLD

HUM

65score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric CVS HUM Winner
Forward P/E 10.6724 24.3309 CVS
PEG Ratio 0.2113 1.2545 CVS
Revenue Growth 7.1% 26.2% HUM
Earnings Growth 188.8% 27.1% CVS
Tradestie Score 65.6/100 64.6/100 CVS
Profit Margin 1.2% 0.9% CVS
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

CVS 1M: -11.1% · 3M: -15.3% HUM 1M: -3.1% · 3M: -1.1%

Current Technical Phase

CVS

Markdown
Sell / avoid

Price below a falling SMA50 (slope -6.0%), weak momentum, RSI 37

RSI (14): 36.8 · Price: $86.46

HUM

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 51

RSI (14): 50.7 · Price: $388.36

Fundamentals Snapshot

Metric CVS HUM
Market Cap — —
Forward P/E 10.1 23.4
Trailing P/E 22.6 35.9
Revenue (TTM) — —
Revenue Growth 0.1% 0.3%
Gross Margin 0.1% 0.1%
Operating Margin 0.0% 0.0%
EPS 3.77 10.57
Dividend Yield 0.03% 0.01%

Frequently Asked Questions

Based on our detailed analysis, CVS is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.